LEO Pharma Files IND Application to FDA for a Clinical Study of JW1601/LP0190 in the US
BALLERUP, Denmark & SEOUL, Korea--(BUSINESS WIRE)--Aug 27, 2019-- |!| Ludington
BALLERUP, Denmark & SEOUL, Korea--(BUSINESS WIRE)--Aug 27, 2019-- |!| Ludington